• Health Protection Conference Presents Key Trial Findings

Laboratory Products

Health Protection Conference Presents Key Trial Findings

Feb 11 2011

Representatives from Inov8 Science Ltd, presented a scientific poster which provides a correlation between the reduction of airborne pathogens and the reduction of infection rates in NHS hospitals using the AD during the UK Health Protection 2010 Conference held in Warwick.

The conference was attended by specialists in all fields of health protection and served as a showcase for innovative presentations, which demonstrated the latest scientific research and its practical application in three key areas, including preventing and reducing infectious diseases.

Inov8’s Dr Abdel Ezbiri, Chief Scientific Officer and Bob Elen, Business Manager presented quantitative evidence on the correlation between the reduction of bio-burden in hospitals using the Inov8 AD system and the subsequent reduction in cross infection. The evidence was gathered during specific trials conducted in four wards from the Redditch Alexandra Hospital and the Royal Worcester Hospital.

Dr Ezbiri explained: “The findings were positive indeed, as in seven out of eight comparisons with the baseline, the trials showed that there was a significant reduction of environmental bioburden. They also showed that there was a significant reduction in the number of patients infected during the periods when the AD was installed and operational. This demonstrates the strong correlation between bioburden reduction and reduction in patient infection rates.”

The air disinfection system helps to prevent the airborne spread of a wide range of viruses, bacteria and fungus. The AD provides continuous air disinfection with hydroxyl radicals at levels that mimic atmospheric concentrations, which are harmless to humans but extremely effective against bacteria and viruses.

Inov8’s AD system is a winner in the 2009 Smart Solutions Programme for the UK NHS. The system is already in use in clinics and hospitals throughout the world. Inov8 continues to expand internationally through the appointment of specialist distributors.


Digital Edition

ILM 49.5 July

July 2024

Chromatography Articles - Understanding PFAS: Analysis and Implications Mass Spectrometry & Spectroscopy Articles - MS detection of Alzheimer’s blood-based biomarkers LIMS - Essent...

View all digital editions

Events

ADLM 2024

Jul 28 2024 San Diego, CA USA

InaLab 2024

Jul 30 2024 Jakarta, Indonesia

Miconex

Jul 31 2024 Chengdu, China

ACS National Meeting - Fall 2024

Aug 18 2024 Denver, CO, USA

EMC2024

Aug 25 2024 Copenhagen, Denmark

View all events